Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical evaluation of hormonal therapy for carcinoma of the prostate.

× No keyword cloud information.

23 in total

1. Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomy.

Authors: Michele Lodde; Louis Lacombe; Angelo Naselli; Paolo Puppo; Michael Mian; Yves Fradet
Journal: World J Urol Date: 2012-01-24 Impact factor: 4.226

Review 2. Novel techniques for the treatment of localized prostate cancer: evidence of efficacy?

Authors: Marnie R Robinson; Judd W Moul
Journal: Curr Urol Rep Date: 2007-05 Impact factor: 3.092

3. The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.

Authors: Michael J Barry; Michael A Delorenzo; Elizabeth S Walker-Corkery; F Lee Lucas; David C Wennberg
Journal: BJU Int Date: 2006-07-28 Impact factor: 5.588

4. Chest-Wall Metastasis of Prostate Cancer.

Authors: Vlad Matei; Sujata Bhushan
Journal: J Gen Intern Med Date: 2015-03-11 Impact factor: 5.128

Review 5. Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications.

Authors: Lauren Collins; Shehzad Basaria
Journal: Asian J Androl Date: 2012-02-20 Impact factor: 3.285

Review 6. Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care.

Authors: L Collins; N Mohammed; T Ahmad; S Basaria
Journal: J Endocrinol Invest Date: 2012-02-28 Impact factor: 4.256

7. An economic analysis of conservative management versus active treatment for men with localized prostate cancer.

Authors: Daniella J Perlroth; Jay Bhattacharya; Dana P Goldman; Alan M Garber
Journal: J Natl Cancer Inst Monogr Date: 2012-12

8. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist.

Authors: Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal: J Natl Cancer Inst Date: 2006-06-21 Impact factor: 13.506

9. National practice patterns and time trends in androgen ablation for localized prostate cancer.

Authors: Matthew R Cooperberg; Gary D Grossfeld; Deborah P Lubeck; Peter R Carroll
Journal: J Natl Cancer Inst Date: 2003-07-02 Impact factor: 13.506

Review 10. [Androgen deprivation for advanced prostate cancer].

Authors: A Heidenreich; D Pfister; C H Ohlmann; U H Engelmann
Journal: Urologe A Date: 2008-03 Impact factor: 0.639